133 related articles for article (PubMed ID: 17614263)
1. Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion.
Formariz TP; Chiavacci LA; Sarmento VH; Santilli CV; Tabosa do Egito ES; Oliveira AG
Colloids Surf B Biointerfaces; 2007 Oct; 60(1):28-35. PubMed ID: 17614263
[TBL] [Abstract][Full Text] [Related]
2. Structural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin release.
Formariz TP; Chiavacci LA; Sarmento VH; Franzini CM; Silva- AA; Scarpa MV; Santilli CV; Egito ES; Oliveira AG
Colloids Surf B Biointerfaces; 2008 Jun; 63(2):287-95. PubMed ID: 18313903
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin biocompatible O/W microemulsion stabilized by mixed surfactant containing soya phosphatidylcholine.
Formariz TP; Sarmento VH; Silva-Junior AA; Scarpa MV; Santilli CV; Oliveira AG
Colloids Surf B Biointerfaces; 2006 Aug; 51(1):54-61. PubMed ID: 16814997
[TBL] [Abstract][Full Text] [Related]
4. Structure and viscoelastic behavior of pharmaceutical biocompatible anionic microemulsions containing the antitumoral drug compound doxorubicin.
Formariz TP; Chiavacci LA; Scarpa MV; Silva-Júnior AA; Egito ES; Terrugi CH; Franzini CM; Sarmento VH; Oliveira AG
Colloids Surf B Biointerfaces; 2010 May; 77(1):47-53. PubMed ID: 20133113
[TBL] [Abstract][Full Text] [Related]
5. Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
Pestana KC; Formariz TP; Franzini CM; Sarmento VH; Chiavacci LA; Scarpa MV; Egito ES; Oliveira AG
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):253-9. PubMed ID: 18676122
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible microemulsion modifies the pharmacokinetic profile and cardiotoxicity of doxorubicin.
Assumpção JU; Campos ML; Ferraz Nogueira Filho MA; Pestana KC; Baldan HM; Formariz Pilon TP; de Oliveira AG; Peccinini RG
J Pharm Sci; 2013 Jan; 102(1):289-96. PubMed ID: 23150468
[TBL] [Abstract][Full Text] [Related]
7. Biocompatible microemulsion modifies the tissue distribution of doxorubicin.
Candido CD; Campos ML; Correa Vidigal Assumpção JU; Pestana KC; Padilha EC; Carlos IZ; Peccinini RG
J Pharm Sci; 2014 Oct; 103(10):3297-301. PubMed ID: 25100266
[TBL] [Abstract][Full Text] [Related]
8. Fabrication, characterization and pharmacokinetic evaluation of doxorubicin-loaded water-in-oil-in-water microemulsions using a membrane emulsification technique.
Pradhan R; Kim YI; Jeong JH; Choi HG; Yong CS; Kim JO
Chem Pharm Bull (Tokyo); 2014; 62(9):875-82. PubMed ID: 25177016
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
10. Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting.
Guhagarkar SA; Gaikwad RV; Samad A; Malshe VC; Devarajan PV
Int J Pharm; 2010 Nov; 401(1-2):113-22. PubMed ID: 20854883
[TBL] [Abstract][Full Text] [Related]
11. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin.
Wang SN; Deng YH; Xu H; Wu HB; Qiu YK; Chen DW
Eur J Pharm Biopharm; 2006 Jan; 62(1):32-8. PubMed ID: 16226883
[TBL] [Abstract][Full Text] [Related]
13. On the incorporation of the non-steroidal anti-inflammatory naproxen into cationic O/W microemulsions.
Correa MA; Scarpa MV; Franzini MC; Oliveira AG
Colloids Surf B Biointerfaces; 2005 Jun; 43(2):108-14. PubMed ID: 15919187
[TBL] [Abstract][Full Text] [Related]
14. Structural properties induced by the composition of biocompatible phospholipid-based microemulsion and amphotericin B association.
Franzini CM; Pestana KC; Molina EF; Scarpa MV; do Egito ES; de Oliveira AG
J Biomed Nanotechnol; 2012 Apr; 8(2):350-9. PubMed ID: 22515088
[TBL] [Abstract][Full Text] [Related]
15. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning.
Xu X; Chen X; Ma P; Wang X; Jing X
Eur J Pharm Biopharm; 2008 Sep; 70(1):165-70. PubMed ID: 18472256
[TBL] [Abstract][Full Text] [Related]
16. Formation and characterization of ordered bicontinuous microemulsions.
Kogan A; Shalev DE; Raviv U; Aserin A; Garti N
J Phys Chem B; 2009 Aug; 113(31):10669-78. PubMed ID: 19719271
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
Yang Y; Hua C; Dong CM
Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
[TBL] [Abstract][Full Text] [Related]
18. Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linker.
Lavignac N; Nicholls JL; Ferruti P; Duncan R
Macromol Biosci; 2009 May; 9(5):480-7. PubMed ID: 19016501
[TBL] [Abstract][Full Text] [Related]
19. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
Hu FQ; Wu XL; Du YZ; You J; Yuan H
Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
[TBL] [Abstract][Full Text] [Related]
20. Water-Tween 40/Imwitor 308-isopropyl myristate microemulsions as delivery systems for ketoprofen: small-angle X-ray scattering study.
Tomsic M; Podlogar F; Gasperlin M; Bester-Rogac M; Jamnik A
Int J Pharm; 2006 Dec; 327(1-2):170-7. PubMed ID: 16930889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
